Mitsubishi Tanabe Pharma Corp Sustainability Reports
The company discovers, develops, manufactures, and markets prescription pharmaceuticals. Its core focus areas include central nervous system disorders, autoimmune conditions, and rare diseases.
Sector: Manufacturing
Country: Japan
Exchange: Tokyo Stock Exchange
ISIN: JP3469000008
2 reports from 2024 to 2025